The purpose of the study protocol is to identify imaging biomarkers for brain tissue under high metabolic stress at risk for permanent injury. We will measure OEF and CVR in participants with and without perturbations in cerebral oxygen delivery over time to determine each parameter's role in clinical and radiologic neurologic outcomes. Measuring OEF can be done with specialized MRI sequences. Measuring CVR requires a vasoactive response, such as carbon dioxide. In order to deliver carbon dioxide evenly and as safely as possible, we will use RespirACT, an MRI-compatible device, to prevent over-breathing carbon dioxide and allow rapid steady-state physiology to minimize total scan time. We will also use an HD-DOT cap to assess the measurement of OEF and CVR.
Age
6–70
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
6-70 Years Old
Able to participate in MRI scan without sedation
May or may not have HbSS or beta thalassemia null genotypes of sickle cell anemia
You may not be if
Significant craniofacial malformation or technical contraindications to DOT monitoring (for HDDOT imaging)
Metal in/on the body that is contraindicated for MRI safety (for MRI imaging)